Myocardial and Microvascular Injury Due to Coronavirus Disease 2019

Over the past few months, health systems worldwide have been put to the test with the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though the leading clinical manifestations of the SARS-CoV-2 infection involve the respirato...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rocco A Montone, Giulia Iannaccone, Maria Chiara Meucci, Filippo Gurgoglione, Giampaolo Niccoli
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2020
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/21ab3b263d704cb68eb18440257533f9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:21ab3b263d704cb68eb18440257533f9
record_format	dspace
spelling	oai:doaj.org-article:21ab3b263d704cb68eb18440257533f92021-12-04T16:03:13ZMyocardial and Microvascular Injury Due to Coronavirus Disease 201910.15420/ecr.2020.221758-37641758-3756https://doaj.org/article/21ab3b263d704cb68eb18440257533f92020-06-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2020.22https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Over the past few months, health systems worldwide have been put to the test with the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though the leading clinical manifestations of the SARS-CoV-2 infection involve the respiratory tract, there is a non-negligible risk of systemic involvement leading to the onset of multi-organ failure with fatal consequences. Since the onset of COVID-19, patients with underlying cardiovascular disease have been at increased risk of poor clinical outcomes with higher death rates. Moreover, the occurrence of new-onset cardiac complications is not uncommon among patients hospitalised for COVID-19. Of importance, a significant portion of COVID-19 patients present with myocardial injury. Herein, the authors discuss the mechanisms leading to myocardial and microvascular injury in SARS-CoV-2 infection and their clinical implications.Rocco A MontoneGiulia IannacconeMaria Chiara MeucciFilippo GurgoglioneGiampaolo NiccoliRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 15, Iss , Pp - (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Rocco A Montone Giulia Iannaccone Maria Chiara Meucci Filippo Gurgoglione Giampaolo Niccoli Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
description	Over the past few months, health systems worldwide have been put to the test with the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though the leading clinical manifestations of the SARS-CoV-2 infection involve the respiratory tract, there is a non-negligible risk of systemic involvement leading to the onset of multi-organ failure with fatal consequences. Since the onset of COVID-19, patients with underlying cardiovascular disease have been at increased risk of poor clinical outcomes with higher death rates. Moreover, the occurrence of new-onset cardiac complications is not uncommon among patients hospitalised for COVID-19. Of importance, a significant portion of COVID-19 patients present with myocardial injury. Herein, the authors discuss the mechanisms leading to myocardial and microvascular injury in SARS-CoV-2 infection and their clinical implications.
format	article
author	Rocco A Montone Giulia Iannaccone Maria Chiara Meucci Filippo Gurgoglione Giampaolo Niccoli
author_facet	Rocco A Montone Giulia Iannaccone Maria Chiara Meucci Filippo Gurgoglione Giampaolo Niccoli
author_sort	Rocco A Montone
title	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
title_short	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
title_full	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
title_fullStr	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
title_full_unstemmed	Myocardial and Microvascular Injury Due to Coronavirus Disease 2019
title_sort	myocardial and microvascular injury due to coronavirus disease 2019
publisher	Radcliffe Medical Media
publishDate	2020
url	https://doaj.org/article/21ab3b263d704cb68eb18440257533f9
work_keys_str_mv	AT roccoamontone myocardialandmicrovascularinjuryduetocoronavirusdisease2019 AT giuliaiannaccone myocardialandmicrovascularinjuryduetocoronavirusdisease2019 AT mariachiarameucci myocardialandmicrovascularinjuryduetocoronavirusdisease2019 AT filippogurgoglione myocardialandmicrovascularinjuryduetocoronavirusdisease2019 AT giampaoloniccoli myocardialandmicrovascularinjuryduetocoronavirusdisease2019
_version_	1718372721991090176

Myocardial and Microvascular Injury Due to Coronavirus Disease 2019

Ejemplares similares